2026 Q2 Portfolio Activity
In 2026 Q2, Sands Capital Alternatives, LLC maintained a portfolio of 24 distinct positions. They heavily accumulated shares in ALAMAR BIOSCIENCES INC, increasing the position by 69.2%. The fund also reduced its exposure to SPYGLASS PHARMA INC by 98.7%.
Position History
hover any row below to update
Loading…
Total Positions
24
Quarter
2026 Q2
Top Holding
N/A (18.7%)
Top 10 Concentration
80.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-24 of 24
Sands Capital Alternatives, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
ALAMAR BIOSCIEN...
|
|
Unknown | 18.68% | — |
#1
Prev: #—
|
9.5 |
—
|
4,230,926 | — |
NEW
|
4,230,926 | $114,615,785 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
NU
NU HLDGS LTD
|
Financial Services | 15.45% | 22.30% |
#2
1
Prev: #1
|
7.5 |
—
|
557,183 | 8.5% |
P
S
|
7,094,952 | $94,788,559 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
KVYO
KLAVIYO INC
|
Technology | 9.67% | 16.86% |
#3
1
Prev: #2
|
6.9 |
—
|
278,468 | 7.6% |
P
S
|
3,928,146 | $59,315,005 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 9.47% | 8.82% |
#4
Prev: #4
|
5.3 |
—
|
no change | no change |
P
S
|
3,708,043 | $58,105,034 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
SPYGLASS PHARMA...
|
|
Unknown | 9.07% | 15.38% |
#5
2
Prev: #3
|
5.1 |
—
|
no change | no change |
P
S
|
2,500,012 | $55,650,267 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
IKT
INHIBIKASE THER...
|
Healthcare | 4.31% | 5.19% |
#6
1
Prev: #5
|
2.7 |
—
|
no change | no change |
P
S
|
13,018,965 | $26,428,499 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DASH
DOORDASH INC
|
Consumer Cyclical | 3.84% | 3.97% |
#7
1
Prev: #8
|
3.5 |
—
|
16,331 | 14.7% |
P
S
|
127,562 | $23,539,016 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CPNG
COUPANG INC
|
Consumer Cyclical | 3.76% | 4.54% |
#8
2
Prev: #6
|
4.0 |
—
|
317,223 | 31.3% |
P
S
|
1,329,314 | $23,090,184 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DDOG
DATADOG INC
|
Technology | 3.43% | 2.40% |
#9
2
Prev: #11
|
1.9 |
—
|
-4,942 | -5.8% |
P
S
|
80,851 | $21,050,366 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 3.14% | 3.27% |
#10
1
Prev: #9
|
2.3 |
—
|
no change | no change |
P
S
|
786,353 | $19,273,512 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TXG
10X GENOMICS IN...
|
Healthcare | 3.01% | 2.43% |
#11
1
Prev: #10
|
2.2 |
—
|
no change | no change |
P
S
|
481,770 | $18,471,062 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IOT
SAMSARA INC
|
Technology | 2.73% | 4.22% |
#12
5
Prev: #7
|
1.6 |
—
|
-44,629 | -8.0% |
P
S
|
515,658 | $16,722,789 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
ODYSSEY THERAPE...
|
|
Unknown | 2.67% | — |
#13
Prev: #—
|
4.6 |
—
|
875,000 | — |
NEW
|
875,000 | $16,371,250 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
TOST
TOAST INC
|
Technology | 1.65% | 1.90% |
#14
1
Prev: #13
|
3.2 |
—
|
63,232 | 21.0% |
P
S
|
364,879 | $10,150,934 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ABOS
ACUMEN PHARMACE...
|
Healthcare | 1.62% | 2.08% |
#15
3
Prev: #12
|
1.6 |
—
|
no change | no change |
P
S
|
3,720,105 | $9,932,680 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TTAN
SERVICETITAN IN...
|
Technology | 1.25% | 1.35% |
#16
1
Prev: #15
|
3.0 |
—
|
18,689 | 20.8% |
P
S
|
108,545 | $7,675,217 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
CEREBRAS SYSTEM...
|
|
Unknown | 1.18% | — |
#17
Prev: #—
|
4.0 |
—
|
32,825 | — |
NEW
|
32,825 | $7,254,325 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
SNOW
SNOWFLAKE INC
|
Technology | 1.02% | 0.73% |
#18
Prev: #18
|
2.9 |
—
|
4,245 | 21.0% |
P
S
|
24,498 | $6,234,741 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MNDY
MONDAY COM LTD
|
Technology | 0.97% | 1.11% |
#19
3
Prev: #16
|
2.9 |
—
|
14,114 | 20.8% |
P
S
|
81,982 | $5,934,677 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.87% | 1.42% |
#20
6
Prev: #14
|
1.3 |
—
|
no change | no change |
P
S
|
85,000 | $5,349,900 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.80% | 0.77% |
#21
4
Prev: #17
|
1.3 |
—
|
no change | no change |
P
S
|
724,873 | $4,936,385 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CADL
CANDEL THERAPEU...
|
Healthcare | 0.68% | 0.47% |
#22
2
Prev: #20
|
1.3 |
—
|
no change | no change |
P
S
|
405,837 | $4,180,121 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACRV
ACRIVON THERAPE...
|
Healthcare | 0.66% | 0.70% |
#23
4
Prev: #19
|
2.3 |
—
|
166,666 | 7.9% |
P
S
|
2,289,271 | $4,074,902 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
FIG
FIGMA INC
|
Technology | 0.07% | 0.09% |
#24
3
Prev: #21
|
2.5 |
—
|
3,879 | 21.2% |
P
S
|
22,165 | $400,965 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-24 of 24 holdings